James Balls draws on his background as a patent examiner and research scientist to help domestic and international companies develop effective strategies to protect critical IP assets. With experience in a wide range of technologies, including the pharmaceutical, chemical, biotechnology and mechanical arts, James assists clients in drafting and prosecuting patent applications in these areas.
He has assisted pharmaceutical companies in developing strategies for protecting critical IP assets while providing guidance throughout the introduction of new products. He has also engaged in litigation and counseling matters by providing infringement, validity, clearance and enforceability opinions. He has extensive litigation experience involving Abbreviated New Drug Application ("ANDA") challenges under the Hatch-Waxman Act. In addition to his work in the field of pharmaceutical products, James also has experience in managing assets such as food products, cosmetics, semiconductors, and medical devices.
Before his law career, James was as a research scientist at a pharmaceutical company in Japan. He worked primarily in the discovery and development of new prescription drugs and the development of over-the-counter vitamin and energy drinks.
James also worked for an aerospace and ammunitions company where he was responsible for managing a team of technicians carrying out chemical testing on propellants used in government defense missiles and NASA space shuttles.